EBELE EZENWA: Open Payments
NPI 1790160653 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 8 payments from 8 companies in 2025. Trend: 2023 $1,065 · 2024 $971 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $150 |
| Abbott Laboratories | 1 | $138 |
| CVRx, Inc. | 1 | $138 |
| Boston Scientific Corporation | 1 | $129 |
| ARGENX US, INC. | 1 | $116 |
| Novo Nordisk Inc | 1 | $116 |
| Paratek Pharmaceuticals, Inc. | 1 | $114 |
| SANOFI PASTEUR INC. | 1 | $102 |
Products named: DEXCOM G7 GSS (161), THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Barostim Neo System, WATCHMAN FLX, VYVGART, Ozempic, NUZYRA.
Industry payments across FL — which companies pay providers there.
